These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 577329)

  • 1. C-peptide in diabetic children after stimulation with clucagon compared with fasting C-peptide levels in non-diabetic children.
    Ludvigsson J; Heding LG
    Acta Endocrinol (Copenh); 1977 Jun; 85(2):364-71. PubMed ID: 577329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal proinsulin/C-peptide ratio in juvenile diabetes.
    Ludvigsson J; Heding L
    Acta Diabetol Lat; 1982; 19(4):351-8. PubMed ID: 6758459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C-peptide in children with juvenile diabetes. A preliminary report.
    Ludvigsson J; Heding LG
    Diabetologia; 1976 Dec; 12(6):627-30. PubMed ID: 1001852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human plasma C-peptide immunoreactivity: its correlation with immunoreactive insulin in diabetes, and chronic liver and renal diseases.
    Kajinuma H; Kanazawa Y; Sando H; Hayashi M; Kawazu S; Kosaka K
    Endocrinol Jpn; 1979 Feb; 26(1):65-73. PubMed ID: 436802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The diagnostic value of serum C-peptide determination].
    Kober G; Rainer OH
    Acta Med Austriaca; 1983; 10(2-3):67-70. PubMed ID: 6349209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disproportionately elevated proinsulin levels precede the onset of insulin-dependent diabetes mellitus in siblings with low first phase insulin responses. The Childhood Diabetes in Finland Study Group.
    Røder ME; Knip M; Hartling SG; Karjalainen J; Akerblom HK; Binder C
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1570-5. PubMed ID: 7989457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients.
    Creutzfeldt WO; Kleine N; Willms B; Orskov C; Holst JJ; Nauck MA
    Diabetes Care; 1996 Jun; 19(6):580-6. PubMed ID: 8725855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus.
    Faber OK; Binder C
    Diabetes; 1977 Jul; 26(7):605-10. PubMed ID: 326604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-peptide in juvenile diabetes.
    Ludvigsson J; Heding LG
    Acta Paediatr Scand Suppl; 1977; (270):53-62. PubMed ID: 356517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma C-peptide response to arginine in insulin-dependent diabetic subjects.
    Giugliano D; Luyckx AS; Lefebvre PJ
    J Endocrinol Invest; 1980; 3(1):19-23. PubMed ID: 6989887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circadian variations in plasma immunoreactive insulin (IRI) and C-peptide concentrations in adult onset (type II) diabetes mellitus.
    Nicolau GY; Haus E; Lakatua DJ; Bogdan C; Petrescu E; Sackett-Lundeen L; Stelea S; Stelea P
    Endocrinologie; 1984; 22(1):3-16. PubMed ID: 6369501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blood serum levels of C-peptide and insulin in diabetics and healthy persons after intravenous administration of glucagon and glucose].
    Jayyab AK; Heding LG; Czyzyk A; Malczewski B; Krókewski AS
    Pol Arch Med Wewn; 1980 Sep; 64(3):229-38. PubMed ID: 7003563
    [No Abstract]   [Full Text] [Related]  

  • 13. Human C-peptide. Part II: Clinical studies.
    Beischer W; Heinze E; Keller L; Raptis S; Kerner W; Pfeiffer EF
    Klin Wochenschr; 1976 Aug; 54(15):717-25. PubMed ID: 824496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basal and glucagon-stimulated plasma C-peptide concentrations in healthy dogs, dogs with diabetes mellitus, and dogs with hyperadrenocorticism.
    Montgomery TM; Nelson RW; Feldman EC; Robertson K; Polonsky KS
    J Vet Intern Med; 1996; 10(3):116-22. PubMed ID: 8743209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum C peptide and IRI levels after administration of glucagon and glucose in non-insulin-dependent diabetics.
    Jayyab AK; Heding LG; Czyzyk A; Malczewski B; Królewski AS
    Horm Metab Res; 1982 Mar; 14(3):112-6. PubMed ID: 7040196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diurnal variation of blood ketone bodies in insulin-dependent diabetes mellitus and noninsulin-dependent diabetes mellitus patients: the relationship to serum C-peptide immunoreactivity and free insulin.
    Ubukata E
    Ann Nutr Metab; 1990; 34(6):333-42. PubMed ID: 2076025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin/C-peptide response to intravenous glucagon. A dose-response study in normal and non-insulin-dependent diabetic subjects.
    Snorgaard O; Hasselstrøm K; Lumholtz IB; Thorsteinsson B; Siersbaek-Nielsen K
    Acta Endocrinol (Copenh); 1988 Jan; 117(1):109-15. PubMed ID: 3289292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of glucagon-like peptide 1 (7-36 amide) on insulin-mediated glucose uptake in patients with type 1 diabetes.
    Meneilly GS; McIntosh CH; Pederson RA; Habener JF; Ehlers MR; Egan JM; Elahi D
    Diabetes Care; 2003 Mar; 26(3):837-42. PubMed ID: 12610046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-types, C-peptide and insulin antibodies in juvenile diabetes.
    Ludvigsson J; Säfwenberg J; Heding LG
    Diabetologia; 1977 Jan; 13(1):13-7. PubMed ID: 838199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Plasma insulin, C-peptide and glucose concentrations in type I diabetic children after a morning injection of insulin (author's transl)].
    Desjeux JF; Vicq D; Gouedard H; Dieterlen P; Gernez-Lestradet C; Lestradet H
    Arch Fr Pediatr; 1981; 38(6):411-5. PubMed ID: 7027987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.